Clinical trial
A Multicenter, Non-comparative, Open-labeled, Prospective Study to Evaluate the Efficacy and Safety of Tacrolimus (Prograf®) With Steroid in Korean Lupus Nephritis Patients Who Are Non-responders to Steroid Monotherapy
NCT01316133 is registered in ClinicalTrials.gov with Astellas Pharma Korea, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Non-comparative, Open-labeled, Prospective Study to Evaluate the Efficacy and Safety of Tacrolimus (Prograf®) With Steroid in Korean Lupus Nephritis Patients Who Are Non-responders to Steroid Monotherapy
- Lead sponsor
- Astellas Pharma Korea, Inc.
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- April 19, 2011
- Completion date
- April 8, 2016
- Enrollment
- 37 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.